Top news of the week: 01.04.2021.
Career And Jobs
2021 Biopharma Update on the Novel Coronavirus: March 30
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for March 30, 2021.
BioSpace Movers & Shakers, March 26
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
Former Merck Exec Joins Flagship to Helm AI Startup Generate Biomedicines
Michael T. Nally became the latest Merck executive to join Flagship Pioneering, taking the reins of its machine learning protein therapy company Generate Biomedicines.
Biogen's Aducanumab: A Look at the Drug’s History and Recent Updates
One of the big drugs investors, analysts and pretty much everyone else in the biopharma industry is keeping an eye on is Biogen and Eisai’s aducanumab for Alzheimer’s disease.
How Biden’s infrastructure plan will go after biopharma companies beyond drug pricing
The White House early Wednesday unveiled a detailed plan for Congress to pass a $2 trillion investment in US infrastructure, with details on how President Biden will attack multinational ...
Phycus Biotechnologies and TeselaGen Biotechnology Partner to Accelerate the Production of Biome-friendly Ingredients for Cosmetics
Collaboration and licensing agreement provide access to TeselaGen, the leading artificial-intelligence-enabled operating system for biotechnology TORONTO AND SAN FRANCISCO (PRWEB) MARCH 31, ...
British T-cell cancer biotech Achilles Therapeutics guns for $176M IPO
Achilles Therapeutics is looking for a meaty $176 million initial public offering for its next-gen immuno-oncology work.
Cytel opens Solara to general release & launches new Trial Optimization Solution for Biotechs
WALTHAM, MASS (March 29, 2021) After months of successfully deploying its new strategic decision-support software Solara, Cytel Inc., a leader in the field of clinical trial design and ...